Nadia Sundlass, MD, PhD, FAAD
As a dermatologist, Dr. Nadia Sundlass is committed to helping teach her patients about their skin and to encourage them to reach their skin health and quality of life goals in a cost-conscious way. Dr. Sundlass specializes in skin cancer detection and treatment and complex medical dermatology, including immunobullous diseases, rashes and eczema. She also takes special interest in managing dermatologic complications of cancer therapy to minimize treatment interruptions and maximize the patient’s quality of life.
- Education
-
Undergraduate Degree:
BS, University of Wisconsin – Madison, WIDoctorate Degree:
PhD, University of Wisconsin – Madison, WIMedical School:
MD, University of Wisconsin School of Medicine -Madison, WIDermatology Residency:
University of Pittsburgh Medical Center – Pittsburgh, PA - Certificates
- American Board of Dermatology
- Professional Memberships
- American Academy of Dermatology
Pennsylvania Academy of Dermatology
- Publications
N.K. Sundlass, N.T. Woltjen, C. Bhate, J. Ho, and J.C. English III. “Infliximab-induced Linear IgA Bullous Disease in a Patient with Ulcerative Colitis,” (2015) J Clin Case Rep, 5: 597.
N.K. Sundlass, C.H. Eller, Q. Cui, and R.T. Raines. “Contribution of electrostatics to the binding of pancreatic-type ribonucleases to membranes,” (2013) Biochemisry, 52(37): 10293-10299. (PMID 23947917, PMC3839965)
N.K. Sundlass and R.T. Raines. “Arginine residues are more effective than lysine residues in eliciting the cellular uptake of Onconase,” (2011) Biochemistry, 50(47): 10293-10299. (PMID 21980976, PMC3234306)
L. Ma*, N.K. Sundlass*, R.T. Raines, and Q. Cui. “Disruption and formation of surface salt bridges are coupled to DNA binding by integration host factor (IHF): A computational analysis,” (2011) Biochemistry 50(2): 266-275. (*co-first authors) (PMID 21121696, PMC3064960)
J.R. Schmidt, N.K. Sundlass, and J.L. Skinner. “Line shapes and photon echoes within a generalized Kubo model,” (2003) Chem. Phys. Letters, 378: 559-566.
*Age Restriction
For patients scheduling who are under 18 years of age (19 in Alabama) please make sure you have permission from your parent or legal guardian to schedule this appointment. Your parent or legal guardian must accompany you on your initial visit and on certain subsequent visits to provide appropriate informed consent.